Domestic Manufacturing of Important KSMs and APIs
- Approvals have been accorded to 16 applicants under Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country.
- Setting up these plants will make the country self-reliant to a large extent in respect of these Bulk drugs.
- The setting up of these 16 plants will lead to a total committed investment of Rs.348.70 crore and employment generation of about 3,042 by the companies.
- Under the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices, after considering all 28 applications, 14 applications have been approved by the Government with a committed investment of Rs. 873.93 cr. which will lead to utilization of maximum incentive of about Rs1,694 cr. against the total budget outlay of Rs. 3,420 cr.